Publicaciones en colaboración con investigadores/as de Ludwig Maximilian University of Munich (16)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Brain ageing in schizophrenia: evidence from 26 international cohorts via the ENIGMA Schizophrenia consortium

    Molecular Psychiatry, Vol. 28, Núm. 3, pp. 1201-1209

  3. Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults

    Journal of Affective Disorders, Vol. 326, pp. 249-261

2022

  1. Ethical considerations for precision psychiatry: A roadmap for research and clinical practice

    European Neuropsychopharmacology, Vol. 63, pp. 17-34

  2. Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A)

    Journal of Affective Disorders, Vol. 299, pp. 367-376

  3. The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic

    Journal of Affective Disorders, Vol. 299, pp. 393-407

2021

  1. Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit

    Schizophrenia Research, Vol. 227, pp. 10-17

  2. Reconceptualising treatment-resistant depression as difficult-to-treat depression

    The Lancet Psychiatry

2020

  1. The identification, assessment and management of difficult-to-treat depression: An international consensus statement

    Journal of Affective Disorders, Vol. 267, pp. 264-282

2019

  1. 10kin1day: A bottom-up neuroimaging initiative

    Frontiers in Neurology, Vol. 10, Núm. MAY

2015

  1. Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: Implications for intervention

    Schizophrenia Bulletin, Vol. 41, Núm. 3, pp. 584-596

2014

  1. Common variant at 16p11.2 conferring risk of psychosis

    Molecular Psychiatry, Vol. 19, Núm. 1, pp. 108-114

  2. Identifying gene-environment interactions in schizophrenia: Contemporary challenges for integrated, large-scale investigations

    Schizophrenia Bulletin, Vol. 40, Núm. 4, pp. 729-736

2012

  1. Do pre-analytical parameters explain KRAS test sensitivity disparities?

    Journal of Molecular Diagnostics

2011

  1. Common variants at VRK2 and TCF4 conferring risk of schizophrenia

    Human Molecular Genetics, Vol. 20, Núm. 20, pp. 4076-4081

2009

  1. Common variants conferring risk of schizophrenia

    Nature, Vol. 460, Núm. 7256, pp. 744-747